While the biotech sector has outperformed the broader market over the past 12 months, investing in this sector can be risky. As such, the author of today’s article recommends gaining exposure to the sector through exchange-traded funds, noting that “These funds have holdings in a large array of biotech companies, offering investors a well-diversified portfolio in one easy-to-execute trade.” But which of the various biotech ETFs available to investors are the best? CLICK HERE.